Overview
Wenjing Xiong practices practicing medicine in Harbin, China.
Their clinical expertise encompasses Breast Cancer in Men, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Abdominal Obesity Metabolic Syndrome.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wenjing Xiong
Is Wenjing Xiong a top-rated expert for Breast Cancer in Men?
MediFind is an objective health platform that identifies experts based on real-world data. Wenjing Xiong is classified as an Experienced expert for Breast Cancer in Men, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wenjing Xiong participate in research or clinical trials?
Yes. Wenjing Xiong has published 10 articles and abstracts on conditions like Breast Cancer in Men. You can view a list of Wenjing Xiong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Abdominal Obesity Metabolic Syndrome
- B-Cell LymphomaXiong isExperienced. Learn about B-Cell Lymphoma.
- Breast Cancer in MenXiong isExperienced. Learn about Breast Cancer in Men.
- Diffuse Large B-Cell Lymphoma (DLBCL)